A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new research.
At Weill Cornell Medicine—and at many of its peer institutions across the United States—immigrants make rich contributions to research, education and clinical care.
